ANGN - Angion Biomedica EPS beats by $0.19 beats on revenue November, 12 2021 08:00 AM Angion Biomedica Corp. Angion Biomedica (NASDAQ:ANGN): Q3 GAAP EPS of -$0.53 beats by $0.19. Revenue of $1.46M (+75.9% Y/Y) beats by $0.4M. Press Release For further details see: Angion Biomedica EPS beats by $0.19, beats on revenue